Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Single Arm, Multi-centre Trial of Triamcinolone With a GnRH Analog for Castration Resistant Prostate Cancer

NCT07161778 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT07161778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07161778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Single Arm, Multi-centre Trial of Triamcinolone With a GnRH Analog for Castration Resistant Prostate Cancer
Lead sponsor
Barts & The London NHS Trust
Phase
Phase 2
Overall status
Completed
Start date
October 19, 2011
Completion date
September 24, 2020
Enrollment
55 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

castration resistant prostate cancer